ClinicalTrials.Veeva

Menu

Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent Swimmers

S

Sheba Medical Center

Status

Completed

Conditions

Upper Respiratory Tract Infections

Treatments

Dietary Supplement: placebo
Dietary Supplement: vitamin D

Study type

Interventional

Funder types

Other

Identifiers

NCT01215682
SHEBA-10-7762-GDR-CTIL

Details and patient eligibility

About

Background: The medical and economic burden of upper respiratory tract infections (URTIs) is extremely high, while prevention and treatment options are limited. Therefore, there is a constant need for new methods in order to significantly decrease such morbidity. Extensive evidence shows that vitamin D is associated with respiratory health, including in the prevention and treatment of URTIs. Competitive swimmers have a high prevalence of URTIs, and can serve as a model for research in this field.

The study hypothesis is that vitamin D supplementation to young swimmers with low vitamin D levels will reduce the frequency, length, and severity of URTIs and their accompanying functional impairment, while improving cellular immune function and physical function.

Methods: After screening 100 competitive adolescent swimmers to obtain ~60 with low serum levels of vitamin D, this study group will be randomized to receive either vitamin D supplementation (2000 IU/d) or placebo, given in a double blinded fashion for three months. Participants will fill a daily questionnaire regarding frequency, length and severity of URTIs symptoms and functional impairment. Blood will be drawn to evaluate changes in vitamin D status (25(OH)D) and immune function among study participants at the beginning of the study and after supplementation. Physical function on land and in water will also be assessed.

Expected results: Increase in serum 25(OH)D levels following supplementation will significantly decrease the frequency, length and severity of URTI's and their functional impairment, while enhancing the cellular immune system function and physical capacity.

Enrollment

82 patients

Sex

All

Ages

12 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • members of swimming team
  • training at least 15 hours/week
  • low vitamin D plasma levels (<30 ng/ml)
  • signed consent forms

Exclusion criteria

  • chronic health conditions
  • taking prescription medications
  • taking diet supplementations

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

82 participants in 2 patient groups, including a placebo group

vit D
Active Comparator group
Treatment:
Dietary Supplement: vitamin D
placebo
Placebo Comparator group
Treatment:
Dietary Supplement: placebo

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems